Mixed results from latest study of BenevolentAI's dermatitis ointment 06-Apr-2023 By Liza Laws An ointment for patients with mild to moderate skin disease, atopic dermatitis (AD), has had mixed results from its phase 2a study.
BPGbio announces partnership with debra of America to help those suffering skin disease 30-Mar-2023 By Liza Laws Finding a treatment for a skin disease that significantly diminishes the quality of life for those living with it has moved forward to the next phase of trials.